Abstract
The concern regarding late-stent thrombosis with the use of drug-eluting, stents provides the basis for an examination of alternative approaches to stent design. This article outlines the biological mechanisms behind the thrombosis and hence provides a framework for understanding the types of drug actions that will be required for the next generation of stents.
Original language | English |
---|---|
Pages (from-to) | 30, 32-33 |
Number of pages | 3 |
Journal | Medical Device Technology |
Volume | 18 |
Issue number | 3 |
Publication status | Published - 1 May 2007 |
Keywords
- stents
- thrombosis
- stent design
- drug actions